Transgenic overexpression of CTRP3 has been shown to prevent both alcoholic and nonalcoholic fatty liver disease in rodent studies (Peterson et al., 2013; Trogen et al., 2018). This evidence concerns the gene C1QTNF3 and metabolic dysfunction-associated steatotic liver disease.